1. Home
  2. GHRS vs VTS Comparison

GHRS vs VTS Comparison

Compare GHRS & VTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • VTS
  • Stock Information
  • Founded
  • GHRS 2018
  • VTS 2014
  • Country
  • GHRS Ireland
  • VTS United States
  • Employees
  • GHRS N/A
  • VTS N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • VTS Oil & Gas Production
  • Sector
  • GHRS Health Care
  • VTS Energy
  • Exchange
  • GHRS Nasdaq
  • VTS Nasdaq
  • Market Cap
  • GHRS 849.8M
  • VTS 824.8M
  • IPO Year
  • GHRS 2021
  • VTS N/A
  • Fundamental
  • Price
  • GHRS $12.31
  • VTS $23.22
  • Analyst Decision
  • GHRS Strong Buy
  • VTS Strong Buy
  • Analyst Count
  • GHRS 8
  • VTS 4
  • Target Price
  • GHRS $30.63
  • VTS $30.25
  • AVG Volume (30 Days)
  • GHRS 187.6K
  • VTS 335.9K
  • Earning Date
  • GHRS 05-08-2025
  • VTS 08-04-2025
  • Dividend Yield
  • GHRS N/A
  • VTS 9.65%
  • EPS Growth
  • GHRS N/A
  • VTS N/A
  • EPS
  • GHRS N/A
  • VTS 0.76
  • Revenue
  • GHRS N/A
  • VTS $225,502,000.00
  • Revenue This Year
  • GHRS N/A
  • VTS $31.77
  • Revenue Next Year
  • GHRS N/A
  • VTS $0.74
  • P/E Ratio
  • GHRS N/A
  • VTS $30.70
  • Revenue Growth
  • GHRS N/A
  • VTS 4.90
  • 52 Week Low
  • GHRS $6.00
  • VTS $18.90
  • 52 Week High
  • GHRS $20.50
  • VTS $28.41
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 52.37
  • VTS 56.02
  • Support Level
  • GHRS $12.43
  • VTS $23.35
  • Resistance Level
  • GHRS $13.15
  • VTS $24.23
  • Average True Range (ATR)
  • GHRS 0.99
  • VTS 0.64
  • MACD
  • GHRS -0.14
  • VTS 0.07
  • Stochastic Oscillator
  • GHRS 41.03
  • VTS 58.66

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About VTS Vitesse Energy Inc.

Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.

Share on Social Networks: